Anglo-Swedish pharmaceutical company AstraZeneca and Switzerland’s Roche have announced a partnership to redefine the diagnosis and treatment of cancer care in the Middle East and North Africa. The partnership seeks to remove barriers to biomarker testing and expand access to precision medicines to improve patient outcomes in a region where cancer is expected to double by 2030. Cancer occurs due to genetic mutations that affect the way cells work and grow. Each person’s cancer is unique because mutations differ in type and number and between cancer types. Even people with the same type of cancer may require different treatment. Biomarker testing is a type of molecular or genetic testing t
Hence then, the article about astrazeneca and roche join forces to boost cancer biomarker testing in the middle east and north africa was published today ( ) and is available onGulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( AstraZeneca and Roche join forces to boost cancer biomarker testing in the Middle East and North Africa )